Mark Crossley, Indivior CEO

FDA ap­proves an­oth­er new type of opi­oid over­dose an­ti­dote nasal spray

As more than 100,000 Amer­i­cans con­tin­ue to die every year from the opi­oid over­dose epi­dem­ic, the FDA late Mon­day ap­proved an­oth­er new nasal spray that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.